Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes

Author:

Orsi Emanuela,Solini Anna,Penno Giuseppe,Bonora Enzo,Fondelli Cecilia,Trevisan Roberto,Vedovato Monica,Cavalot Franco,Lamacchia Olga,Haxhi Jonida,Nicolucci Antonio,Pugliese Giuseppe,Laviola Luigi,Bollanti Lucilla,Alessi Elena,Vitale Martina,Cirrito Tiziana,Cavallo-Perin Paolo,Gruden Gabriella,Lorenzati Bartolomeo,Trovati Mariella,Di Martino Leonardo,Mazzaglia Fabio,Zerbini Giampaolo,Martina Valentina,Maestroni Silvia,Capuano Valentina,Palmieri Eva,Lunati Elena,Grancini Valeria,Resi Veronica,Pontiroli Antonio,Veronelli Annamaria,Zecchini Barbara,Arosio Maura,Montefusco Laura,Rossi Antonio,Adda Guido,Corsi Anna,Albizzi Mascia,Zoppini Giacomo,Avogaro Angelo,Pucci Laura,Lucchesi Daniela,Russo Eleonora,Garofolo Monia,Dotta Francesco,Nigi Laura,Morano Susanna,Filardi Tiziana,Turinese Irene,Rossetti Marco,Buzzetti Raffaella,Foffi Chiara,Cignarelli Mauro,Pinnelli Sabina,Monaco Lucia,Giorgino Francesco,Natalicchio Annalisa,Sesti Giorgio,Andreozzi Francesco,Baroni Marco Giorgio,Frau Giuseppina,Boi Alessandra,

Abstract

Abstract Background An “obesity paradox” for mortality has been shown in chronic disorders such as diabetes, and attributed to methodological bias, including the use of body mass index (BMI) for obesity definition. This analysis investigated the independent association of BMI versus surrogate measures of central adiposity with all-cause mortality in individuals with type 2 diabetes. Methods The Renal Insufficiency And Cardiovascular Events Italian Multicentre Study is a prospective cohort study that enrolled 15,773 patients in 19 Italian centres in 2006–2008. Exposures were BMI and the surrogate measures of central adiposity waist circumference (WC), waist-to-height ratio (WHtR), and A Body Shape Index (ABSI). Vital status was retrieved on 31 October 2015 for 15,656 patients (99.3%), Results Age- and sex-adjusted hazard ratios and 95% confidence intervals were significantly higher in BMI-based underweight (1.729 [1.193–2.505), P = 0.004), moderately obese (1.214 [1.058–1.392), P = 0.006) and severely obese (1.703 [1.402–2.068), P < 0.0001), lower in overweight (0.842 [0.775–0.915), P < 0.0001) and similar in mildly obese (0.950 [0.864–1.045), P = 0.292), compared to normal-weight individuals. When further adjusting for smoking, physical activity (PA), and comorbidities, risk was lower also in mildly obese versus normal-weight patients. The BMI-mortality relationship did not change after sequentially excluding ever smokers, individuals with comorbidities, and those died within two years from enrollment and when analyzing separately participants below and above the median age. Conversely, a paradox relationship was observed among inactive/moderately inactive, but not moderately/highly active patients. Mortality risk adjusted for age, gender, smoking, PA and comorbidities was significantly higher in the highest tertile of WC (1.279 [1.089–1.501], P = 0.003), WHtR (1.372 [1.165–1.615], P < 0.0001), and ABSI (1.263 [1.067–1.495], P = 0.007) versus the lowest tertile. However, risk was lower in the intermediate versus lowest tertile for WC (0.823 [0.693–0.979], P = 0.028), similar for WHtR, and higher, though not significantly, for ABSI. Conclusions An “overweight paradox” remained after controlling for age, smoking, and comorbidities, arguing against a collider bias or reverse causation. However, it could be partly explained by confounding from PA level, possibly through its impact on lean mass and cardiorespiratory fitness. No obesity paradox was observed with WHtR and especially ABSI, which predicted mortality risk associated with central adiposity better than WC. Trial registration ClinicalTrials.gov, NCT00715481, 15 July, 2008

Funder

Fondazione Diabete Ricerca

Diabetes, Endocrinology and Metabolism Foundation

Eli Lilly and Company

Sigma-Tau Pharmaceuticals

Boehringer Ingelheim

Chiesi Farmaceutici

Takeda Pharmaceutical Company

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3